109 related articles for article (PubMed ID: 22550026)
21. Molecular interactions of the Src homology 2 domain protein Shb with phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain proteins.
Karlsson T; Songyang Z; Landgren E; Lavergne C; Di Fiore PP; Anafi M; Pawson T; Cantley LC; Claesson-Welsh L; Welsh M
Oncogene; 1995 Apr; 10(8):1475-83. PubMed ID: 7537362
[TBL] [Abstract][Full Text] [Related]
22. SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.
Wang B; Lemay S; Tsai S; Veillette A
Mol Cell Biol; 2001 Feb; 21(4):1077-88. PubMed ID: 11158295
[TBL] [Abstract][Full Text] [Related]
23. Determination of affinities for lck SH2 binding peptides using a sensitive fluorescence assay: comparison between the pYEEIP and pYQPQP consensus sequences reveals context-dependent binding specificity.
Cousins-Wasti RC; Ingraham RH; Morelock MM; Grygon CA
Biochemistry; 1996 Dec; 35(51):16746-52. PubMed ID: 8988011
[TBL] [Abstract][Full Text] [Related]
24. Regulation of c-Src tyrosine kinase activity by the Src SH2 domain.
Liu X; Brodeur SR; Gish G; Songyang Z; Cantley LC; Laudano AP; Pawson T
Oncogene; 1993 May; 8(5):1119-26. PubMed ID: 7683128
[TBL] [Abstract][Full Text] [Related]
25. Thymocyte activation induces the association of phosphatidylinositol 3-kinase and pp120 with CD5.
Dennehy KM; Broszeit R; Garnett D; Durrheim GA; Spruyt LL; Beyers AD
Eur J Immunol; 1997 Mar; 27(3):679-86. PubMed ID: 9079809
[TBL] [Abstract][Full Text] [Related]
26. Focal adhesion kinase-dependent focal adhesion recruitment of SH2 domains directs SRC into focal adhesions to regulate cell adhesion and migration.
Wu JC; Chen YC; Kuo CT; Wenshin Yu H; Chen YQ; Chiou A; Kuo JC
Sci Rep; 2015 Dec; 5():18476. PubMed ID: 26681405
[TBL] [Abstract][Full Text] [Related]
27. Crystal structures of the human p56lck SH2 domain in complex with two short phosphotyrosyl peptides at 1.0 A and 1.8 A resolution.
Tong L; Warren TC; King J; Betageri R; Rose J; Jakes S
J Mol Biol; 1996 Mar; 256(3):601-10. PubMed ID: 8604142
[TBL] [Abstract][Full Text] [Related]
28. Targeting Self-Binding Peptides as a Novel Strategy To Regulate Protein Activity and Function: A Case Study on the Proto-oncogene Tyrosine Protein Kinase c-Src.
Bai Z; Hou S; Zhang S; Li Z; Zhou P
J Chem Inf Model; 2017 Apr; 57(4):835-845. PubMed ID: 28345935
[TBL] [Abstract][Full Text] [Related]
29. Conformational basis for SH2-Tyr(P)527 binding in Src inactivation.
Ayrapetov MK; Wang YH; Lin X; Gu X; Parang K; Sun G
J Biol Chem; 2006 Aug; 281(33):23776-84. PubMed ID: 16790421
[TBL] [Abstract][Full Text] [Related]
30. A Focal Adhesion Kinase-Derived Peptide Binds the Src SH3 Domain in Two Orientations, As Demonstrated Using Paramagnetic Nuclear Magnetic Resonance.
Somireddy Venkata B; Keizers PH; Drijfhout JW; Ubbink M
Biochemistry; 2016 Jan; 55(1):29-37. PubMed ID: 26645346
[TBL] [Abstract][Full Text] [Related]
31. Specific interactions of neuronal focal adhesion kinase isoforms with Src kinases and amphiphysin.
Messina S; Onofri F; Bongiorno-Borbone L; Giovedì S; Valtorta F; Girault JA; Benfenati F
J Neurochem; 2003 Jan; 84(2):253-65. PubMed ID: 12558988
[TBL] [Abstract][Full Text] [Related]
32. A Discovery Strategy for Selective Inhibitors of c-Src in Complex with the Focal Adhesion Kinase SH3/SH2-binding Region.
Moroco JA; Baumgartner MP; Rust HL; Choi HG; Hur W; Gray NS; Camacho CJ; Smithgall TE
Chem Biol Drug Des; 2015 Aug; 86(2):144-55. PubMed ID: 25376742
[TBL] [Abstract][Full Text] [Related]
33. Estrogen Receptor Folding Modulates cSrc Kinase SH2 Interaction via a Helical Binding Mode.
Nieto L; Tharun IM; Balk M; Wienk H; Boelens R; Ottmann C; Milroy LG; Brunsveld L
ACS Chem Biol; 2015 Nov; 10(11):2624-32. PubMed ID: 26352092
[TBL] [Abstract][Full Text] [Related]
34. Crystal structure of the FERM domain of focal adhesion kinase.
Ceccarelli DF; Song HK; Poy F; Schaller MD; Eck MJ
J Biol Chem; 2006 Jan; 281(1):252-9. PubMed ID: 16221668
[TBL] [Abstract][Full Text] [Related]
35. Grb7 SH2 domain structure and interactions with a cyclic peptide inhibitor of cancer cell migration and proliferation.
Porter CJ; Matthews JM; Mackay JP; Pursglove SE; Schmidberger JW; Leedman PJ; Pero SC; Krag DN; Wilce MC; Wilce JA
BMC Struct Biol; 2007 Sep; 7():58. PubMed ID: 17894853
[TBL] [Abstract][Full Text] [Related]
36. Calorimetric and structural studies of 1,2,3-trisubstituted cyclopropanes as conformationally constrained peptide inhibitors of Src SH2 domain binding.
Davidson JP; Lubman O; Rose T; Waksman G; Martin SF
J Am Chem Soc; 2002 Jan; 124(2):205-15. PubMed ID: 11782172
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of site-directed spin labeling for characterizing protein-ligand complexes using simulated restraints.
Constantine KL
Biophys J; 2001 Sep; 81(3):1275-84. PubMed ID: 11509344
[TBL] [Abstract][Full Text] [Related]
38. Mobility of TOAC spin-labelled peptides binding to the Src SH3 domain studied by paramagnetic NMR.
Lindfors HE; de Koning PE; Drijfhout JW; Venezia B; Ubbink M
J Biomol NMR; 2008 Jul; 41(3):157-67. PubMed ID: 18560762
[TBL] [Abstract][Full Text] [Related]
39. High resolution crystal structure of the FAK FERM domain reveals new insights on the Druggability of tyrosine 397 and the Src SH3 binding site.
Marlowe T; Dementiev A; Figel S; Rivera A; Flavin M; Cance W
BMC Mol Cell Biol; 2019 May; 20(1):10. PubMed ID: 31109284
[TBL] [Abstract][Full Text] [Related]
40. Sequence, structure and energetic determinants of phosphopeptide selectivity of SH2 domains.
Sheinerman FB; Al-Lazikani B; Honig B
J Mol Biol; 2003 Dec; 334(4):823-41. PubMed ID: 14636606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
